Mantle cell lymphoma cell lines show no evident immunoglobulin heavy chain stereotypy but frequent light chain stereotypy

Leukemia and Lymphoma

Volumn 54, Issue 8, 2013, Pages 1747-1755

  Pighi, Chiara ^a   Barbi, Stefano ^a   Bertolaso, Anna ^a   Zamò, Alberto ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

B cell receptor; Immunogenetics; Mantle cell lymphoma; Stereotypy

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ARTICLE; CANCER GENETICS; CONTROLLED STUDY; GENE CLUSTER; GENE REARRANGEMENT; GENE SEQUENCE; HEAVY CHAIN; IMMUNOGENETICS; LIGHT CHAIN; LYMPHOMA CELL LINE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STEREOTYPY; TUMOR CELL LINE;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; CLUSTER ANALYSIS; COMPLEMENTARITY DETERMINING REGIONS; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; GENE REARRANGEMENT, B-LYMPHOCYTE, LIGHT CHAIN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; LYMPHOMA, MANTLE-CELL; MOLECULAR SEQUENCE DATA; MUTATION;

EID: 84880261394     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.758843     Document Type: Article

References (65)

1. Achille A, Scarpa A, Montresor M, et al. Routine application of polymerase chain reaction in the diagnosis of monoclonality of B-cell lymphoid proliferations. Diagn Mol Pathol 1995; 4: 14-24
2. van Dongen JJM, Langerak AW, Brggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003 ; 17 : 2257-2317
3. Kuppers R, Zhao M, Rajewsky K and Hansmann ML Detection of clonal B cell populations in paraffi n-embedded tissues by polymerase chain reaction. Am J Pathol 1993 ; 143 : 230-239
4. Garcia-Munoz R, Galiacho V R and L lorente L I mmunological aspects in chronic lymphocytic leukemia (CLL) development. Ann Hematol 2012 ; 91 : 981-996
5. Gobessi S, Laurenti L, Longo P G, et a l. Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells. Leukemia 2009 ; 23 : 686-697
6. Chen L, Monti S, Juszczynski P, et a l. SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma. Blood 2008; 111: 2230-2237
7. Davis R E, Ngo V N, Lenz G, et a l. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 2010; 463: 88-92
8. Swerdlow SH, Campo E, Seto M and Muller-Hermelink HK. Mantle cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H, Thiele J and Vardiman J WHO Classifi cation of Tumours of Haematopoietic and Lymphoid Tissues Lyon: IARC Press; 2008. pp. 229-232
9. Burger J A and Ford R J. The microenvironment in mantle cell lymphoma: Cellular and molecular pathways and emerging targeted therapies. Semin Cancer Biol 2011; 21: 308-312
10. Pighi C, Gu T L, Dalai I, et a l. Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. Cell Oncol (Dordr) 2011
11. Rinaldi A, Kwee I, Taborelli M, et al. Genomic and expression profi ling identifi es the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma. Br J Haematol 2006 ; 132 : 303-316
12. Camacho FI, Algara P, Rodriguez A, et al. Molecular heterogeneity in MCL defi ned by the use of specific VH genes and the frequency of somatic mutations. Blood 2003 ; 101 : 4042-4046
13. Kienle D, Krober A, Katzenberger T, et al. VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: Correlation with genomic aberrations, clinical characteristics, and outcome. Blood 2003 ; 102 : 3003-3009
14. Orchard J, Garand R, Davis Z, et al. Asubset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood 2003 ; 101 : 4975-4981
15. Schraders M, Oeschger S, Kluin P M, et a l. Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentity. Mod Pathol 2009 ; 22 : 416-425
16. Thorselius M, Walsh S, Eriksson I, et al. Somatic hypermutation and V(H) gene usage in mantle cell lymphoma. Eur J Haematol 2002 ; 68 : 217-224
17. Walsh SH, Th orselius M, Johnson A, et al. Mutated VH genes and preferential VH3-21 use defi ne new subsets of mantle cell lymphoma. Blood 2003 ; 101 : 4047-4054
18. Hadzidimitriou A, Agathangelidis A, Darzentas N, et al. Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases. Blood 2011 ; 118 : 3088-3095
19. Bea S, Salaverria I, Armengol L, et al. Uniparental disomies, homozygous deletions, amplifi cations, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profi ling. Blood 2009; 113: 3059-3069
20. Cecconi D, Zamo A, Bianchi E, et al. Signal transduction pathways of mantle cell lymphoma: A phosphoproteome-based study. Proteomics 2008 ; 8 : 4495-4506
21. Vater I, Wagner F, Kreuz M, et al. GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma. Br J Haematol 2009 ; 144 : 317-331
22. Drexler HG and MacLeod RA. Malignant hematopoietic cell lines: In vitro models for the study of mantle cell lymphoma. Leuk Res 2002 ; 26 : 781-787
23. Amin HM, McDonnell TJ, Medeiros LJ, et al. Characterization of 4 mantle cell lymphoma cell lines. Arch Pathol Lab Med 2003 ; 127 : 424-431
24. Ek S, Ortega E and Borrebaeck CA. Transcriptional profi ling. and assessment of cell lines as in vitro models for mantle cell lymphoma. Leuk Res 2005; 29: 205-213
25. Zamo A, Ott G, Katzenberger T, et al. Establishment of the MAVER-1 cell line, amodel for leukemic and aggressive mantle cell lymphoma. Haematologica 2006; 91: 40-47
26. M'Kacher R, Bennaceur A, Farace F, et al. Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma. Oncogene 2003 ; 22 : 7905-7912
27. Kuppers R, Zhao M, Hansmann ML and Rajewsky K. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. Embo J 1993 ; 12 : 4955-4967
28. Fais F, Ghiotto F, Hashimoto S, et a l. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998 ; 102 : 1515-1525
29. Lefranc MP, Giudicelli V, Ginestoux C, et al. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res 1999; 27: 209-212
30. Giudicelli V, Brochet X and Lefranc MP. IMGT/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences. Cold Spring Harb Protoc 2011 ;2011: 695-715
31. Kuppers R, Willenbrock K, Rajewsky K, Hansmann ML. Detection of clonal lambda light chain gene rearrangements in frozen and paraffi n-embedded tissues by polymerase chain reaction. Am J Pathol 1995 ; 147 : 806-814
32. van der Burg M, Tumkaya T, Boerma M, et al. Ordered recombination of immunoglobulin light chain genes occurs at the IGK locus but seems less strict at the IGL locus. Blood 2001 ; 97 : 1001-1008
33. Chen Z, Collins AM, Wang Y and Gaeta BA. Clustering-based identifi cation of clonally-related immunoglobulin gene sequence sets. Immunome Res 6 Suppl 1:S4
34. Darzentas N, Hadzidimitriou A, Murray F, et al. Adifferent ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: Molecular and computational evidence. Leukemia 2010; 24: 125-132
35. Navarro A, Clot G, Royo C, et al. Molecular subsets of mantle cell lymphoma defi ned by the IGHV mutational status and SOX11 expression have distinct biological and clinical features. Cancer Res 2012 ; 72 : 5307-16
36. Bertoni F, Zucca E, Genini D, et al. Immunoglobulin light chain kappa deletion rearrangement as a marker of clonality in mantle cell lymphoma. Leuk Lymphoma 1999; 36: 147-150
37. Binder M, Lechenne B, Ummanni R, et al. Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells. PLoS One 2010; 5: E15992
38. Thelander EF, Walsh SH, Thorselius M, et al. Mantle cell lymphomas with clonal immunoglobulin V(H)3-21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin V(H) genes. Mod Pathol 2005 ; 18 : 331-339
39. Thorselius M, Krober A, Murray F, et a l. Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. Blood 2006 ; 107 : 2889-2894
40. Tobin G, Thunberg U, Johnson A, et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: Implicating recognition of a common antigen epitope. Blood 2003 ; 101 : 4952-4957
41. Tobin G, Thunberg U, Johnson A, et al. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 2002 ; 99 : 2262-2264
42. Bhat NM, Lee LM, van Vollenhoven RF, Teng NN and Bieber MM VH4-34 encoded antibody in systemic lupus erythematosus: Effect of isotype. JRheumatol 2002 ; 29 : 2114-2121
43. Pascual V, Victor K, Spellerberg M, et al. VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-I and anti-ispecifi cities. JImmunol 1992 ; 149 : 2337-2344
44. Riboldi P, Gaidano G, Schettino EW, et al. Two acquired immunodeficiency syndrome-Associated Burkitt's lymphomas produce specific anti-i IgM cold agglutinins using somatically mutated VH4-21 segments. Blood 1994 ; 83 : 2952-2961
45. Silberstein LE, Jefferies LC, Goldman J, et al. Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood 1991 ; 78 : 2372-2386
46. Kostareli E, Hadzidimitriou A, Stavroyianni N, et al. Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors. Leukemia 2009 ; 23 : 919-924
47. Arons E, Suntum T, Stetler-Stevenson M and K reitman R J V H4-34 hairy cell leukemia, anew variant with poor prognosis despite standard therapy. Blood 2009; 114: 4687-4695
48. Lai R, Lefresne SV, Franko B, et al. Immunoglobulin VH somatic hypermutation in mantle cell lymphoma: Mutated genotype correlates with better clinical outcome. Mod Pathol 2006; 19: 1498-1505
49. Papadaki T, Stamatopoulos K, Belessi C, et al. Splenic marginal-zone lymphoma: One or more entities? A histologic, immunohistochemical, and molecular study of 42 cases. Am J Surg Pathol 2007 ; 31 :438-446
50. Arcaini L, Zibellini S, Passamonti F, et a l. Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires. Blood Cells Mol Dis 2009 ; 42 : 286-291
51. Bikos V, Darzentas N, Hadzidimitriou A, et al. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: Ontogenetic implications. Leukemia 2012; 26: 1638-1646
52. Bahler D W, Szankasi P, Kulkarni S, et a l. Use of similar immunoglobulin VH gene segments by MALT lymphomas of the ocular adnexa. Mod Pathol 2009 ; 22 : 833-838
53. Bomben R, Dal Bo M, Capello D, et al. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: Results from an Italian multicentre study. Br J Haematol 2009 ; 144 : 492-506
54. Rettig MB, Vescio RA, Cao J, et al. VH gene usage is multiple myeloma: Complete absence of the VH4.21 (VH4-34) gene. Blood 1996 ; 87 :2846-2852
55. Gonzalez D, van der Burg M, Garcia-Sanz R, et al. Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma. Blood 2007 ; 110 : 3112-3121
56. Wang J, Bu D and Zhu X. Immunoglobulin variable region gene analysis to the autoantibody-secreting B cells from tumors in association with paraneoplastic autoimmune multiorgan syndrome. Int J Dermatol 2007 ; 46 : 1146-1154
57. Lecerf JM, Chen Y, Richalet-Secordel P, Wang X and Stollar BD. Autoreactivity of human VH domains from cDNA libraries: Analysis witha bacterial expression system. JImmunol 1998 ; 161 : 1274-1283
58. Stamatopoulos K, Belessi C, Hadzidimitriou A, et a l. Immunoglobulin light chain repertoire in chronic lymphocytic leukemia. Blood 2005 ; 106 : 3575-3583
59. Ghiotto F, Fais F, Albesiano E, et al. Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukemia. Mol Med 2006; 12: 300-308
60. Hadzidimitriou A, Darzentas N, Murray F, et al. Evidence for the signifi cant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia. Blood 2009 ; 113 : 403-11
61. Kostareli E, Gounari M, Agathangelidis A, Stamatopoulos K. Immunoglobulin gene repertoire in chronic lymphocytic leukemia: Insight into antigen selection and microenvironmental interactions. Mediterr J Hematol Infect Dis 2012; 4 : E2012052
62. Smilevska T, Tsakou E, Hadzidimitriou A, et a l. Immunoglobulin kappa gene repertoire and somatic hypermutation patterns in follicular lymphoma. Blood Cells Mol Dis 2008; 41: 215-8
63. Bikos V, Stalika E, Baliakas P, et al. Selection of antigen receptors in splenic marginal-zone lymphoma: Further support from the analysis of the immunoglobulin light-chain gene repertoire. Leukemia 2012 : 2567-2569
64. Combriato G and Klobeck HG. Vlambda and J lambda-C lambda gene segments of the human immunoglobulin lambda light chain locus are separated by 14 kb. and rearrange by a deletion mechanism. Eur J Immunol 1991 ; 21 : 1513-1522
65. Maura F, Cutrona G, Fabris S, et a l. Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia. PLoS One 2011; 6: E24313